Mechanical Nanosurgery Could Revolutionize Brain Cancer Treatment
Glioblastoma is an aggressive brain cancer that invades brain tissue. The average life expectancy following diagnosis for this cancer is 14 to 16 months. Globally, the standard of care for patients with this type of cancer includes chemotherapy with temozolomide, which extends a patient’s expectancy by about two months. Patients may also undergo radiotherapy as well as surgery to remove tumors. However, even after rigorous treatment cycles, glioblastoma cells may develop resistance to temozolomide over time, heightening the chances of tumor relapse and decreasing its effectiveness. Researchers at the University of Toronto and The Hospital for Sick Children may have…